With news in just last week that the Republican-controlled
House of the Texas Legislature has approved cannabis oil for medicinal
purposes, as the passage of Senate Bill 339, known as the “Texas Compassionate
Use Act,” means Governor Greg Abbott is now within striking distance of
allowing dispensing organizations to obtain a license to dispense low-THC
cannabis in the state, the medical marijuana industry is once again buzzing
about the upper limit potential of this sector. Passage of SB 339 would make Texas
the latest addition to a growing list of states in the U.S. passing similar
landmark medical marijuana (MMJ) legislation, spurred on by mounting scientific
evidence for cannabis-based therapies being able treat the clinically unmet
needs of numerous types of patients, particularly in cases of intractable
epilepsy, where conventional antiepileptic drugs have failed.
The Texas bill’s passage could be big news for a market that
was already estimated to be running around $2.7 billion last year here in the
U.S., according to data from cannabis industry investment and research firm,
ArcView Market Research. ArcView calculated a 74% jump last year over 2013’s
figures for what is, according to their broader analysis, now the fastest
growing industry in the entire country. Projections for this year are in the
neighborhood of $3.5 billion, a figure expected by ArcView to rise a whopping
208% or more by 2019, as more and more states pass not only similar
compassionate care laws decriminalizing some form or other of medical cannabis,
but perhaps even going for blanket legalization like in Colorado, which raked
in some $53 million in tax revenues during their first year of legalization.
One of the more exciting companies in this fast-growing
sector is GrowBLOX Sciences (OTCQB: GBLX), which has developed a host of key
technologies needed to thrive in this yet-nascent industry. GrowBLOX Sciences
has organized itself into three distinct divisions in order to pursue the
company’s bold operational goal set, which spans big data-driven clinical
R&D, as well as cultivation using their proprietary GrowBLOX™ Technology
suite of systems. The company has even organized a commercial product
development division for targeting dispensaries and various other end markets.
You can take a look at the company’s website by visiting www.growblox.com.
The company’s GB Sciences division, which focuses on
scientific validation and new drug discovery, plans to use certified raw
materials matured in the GrowBLOX™ cultivation chambers to develop novel
cannabis-based therapies. Leveraging a data-driven biopharmaceutical
development approach of running therapies through accelerated human phase IV
clinical trials is visionary. This “fast-track” process will be supplemented
and accelerated by the company’s proprietary Patient-Reported Outcomes (PRO)
smartphone app, which will also enhances the company’s ability to test and
refine the chemical ratios of active ingredients. Investors should watch GBLX
closely. The long-term patient data that the company will be aggregating via
their patient-reported outcomes based smartphone app will also help improve the
company’s predictive treatment algorithm approach to therapy development.
Harnessing this data is one of the key advantages the company will have in the long
run, something that will give GBLX a significant edge over competitors.
The current players in the medical cannabis space are just
now scratching the surface of the opportunities that are manifesting at every
turn when applying a comprehensive scientific approach to this booming cannabis
market.
Investors will want to keep a close eye on companies like
GrowBLOX Sciences. As the industry evolves into more than just cultivating a
plant, it will be the new technologies, as well as the data that emerges from
this, that will be of enormous value just around the corner.
For more information, visit www.gbsciences.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment